BBK Worldwide expanded its three decades of expertise in supporting clinical R&D with the introduction of its patient recruitment franchise program at the DIA Annual Meeting in Washington, D.C.
BBK’s flagship product for its new program is the FRANCHISE e-BINDER, a flexible and intuitive communication platform that uses the Apple iPad to facilitate the myriad processes necessary to effectively recruit and manage patients for global clinical trials.
This new franchise model not only realizes significant cost-savings in the execution of patient recruitment programs, the company said, but it also supports quick, efficient enrollment for multiple studies within the same therapeutic category, as well as multiple protocols for a single compound.
“Franchise programs create exponential savings through the economies of scale derived from applying strategies and tactics across multiple studies and countries,” said Joan Bachenheimer, BBK Worldwide founding principal and CEO. “Using the model of the patient recruitment franchise program, sponsors are able to consolidate planning and recruitment strategies for immediate and long-term cost reductions that far exceed preferred pricing or volume discounts.” The Apple iPad supports franchise-level initiatives by making it possible to instantly distribute, store and retrieve information and data.